INVO Bioscience Balance Sheet Health
Financial Health criteria checks 3/6
INVO Bioscience has a total shareholder equity of $10.2K and total debt of $2.9M, which brings its debt-to-equity ratio to 28452.2%. Its total assets and total liabilities are $18.3M and $18.3M respectively.
Key information
28,452.2%
Debt to equity ratio
US$2.89m
Debt
Interest coverage ratio | n/a |
Cash | US$475.13k |
Equity | US$10.16k |
Total liabilities | US$18.31m |
Total assets | US$18.32m |
Financial Position Analysis
Short Term Liabilities: INVO's short term assets ($1.7M) do not cover its short term liabilities ($9.0M).
Long Term Liabilities: INVO's short term assets ($1.7M) do not cover its long term liabilities ($9.4M).
Debt to Equity History and Analysis
Debt Level: INVO's net debt to equity ratio (23773.5%) is considered high.
Reducing Debt: INVO had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INVO has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: INVO is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.